#ASHG20 XX
Deciphering the function of single-nucleotide variants in the RNA.
Xinshu Xiao.
#ASHG20 XX How do you go from genotype to phenotypes with so much genetic data? Long way to go to tackle this challenge. Many different players from genotypes - phenotypes. Complex, interacting pathways lead to final phenotype.
#ASHG20 XX Many steps exist between RNA expression to degradation. Alternative polyadenylation. Alternative isoforms. RNA editing. From same DNA sequence diverse spectrum of RNA molecules can be produced.
#ASHG20 XX One of these steps is pre-mRNA splicing. Controlled by cis-acting motifs and trans-acting proteins. Complex network to control splicing decisions. Many RNA-binding proteins recognize specific RNA motifs. Means motif disruption can change binding kinetics.
#ASHG20 XX How do you identify these variants? One approach is to look for proteins that exhibit allele-specific binding to a particular target.
#ASHG20 XX transcriptome-wide discovery of ribosomal binding proteins (RBP) using eCLIP-seq.
#ASHG20 XX Use new method, BEAPR, to identify allele-specific binding from eCLIP data. bit.ly/389maL9
#ASHG20 XX What is the functional consequence of allele-specific binding? Allele-specific splicing can be detected from RNA-Seq data.
#ASHG20 XX Allele-specific alternative splicing they are also calling genetically modulated alternative splicing (GMAS) events. Looked for these patterns in GTEx. Predict causal SNPs from GMAS events.
#ASHG20 XX How do GMAS patterns vary across tissues and individuals? Roughly equivalent variability between individuals as between tissues. [ Interesting! ]
#ASHG20 XX Low variance genes are often related to essential cellular function. Lots of variability in immune-system and immune-response genes.
#ASHG20 XX Concordance analysis. Looks to be able to model with Gaussian distributions. Help identify which SNP is functionally driving effect. Identified >1k putatively causative SNPs. Show positional bias around splice sites.
#ASHG20 XX 72% of GMAS SNPs are in LD with GWAS SNPs. Individual GWAS traits, see biggest relative enrichment with immune function and particular neurological disease categories.
#ASHG20 XX What tissues are enriched with each phenotype? GMAS enriched in brain-related tissues for bipolar trait GWAS hits.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
#ASHG20 HYC
Genome Regulation by Long Noncoding RNAs.
Howard Y. Chang.
#ASHG20 HYC RNA localizatin is both a prevalent phenomenon and an important one. Variation that affects RNA localization can lead to phenotypic differences.
#ASHG20 HYC If you understand where RNA is going you can understand more about what it does.
#ASHG20 MAC
Impairment of the mitochondrial one-carbon metabolism enzyme SHMT2 causes a novel brain and heart developmental syndrome.
Margot A. Cousin.
#ASHG20 MAC SHMT2 encodes the mitochrondrial serine hydroxymethyltransferase 2. Loss embryonic lethal in mice. Both mitochondrial and cytosolic functions.
#ASHG20 MAC [ primarily mitochondrial though. ] Individuals with biallelic SHMT2 variants - 5 individuals with similar phenotypes from 4 families.
#ASHG20 HCM
Increased p4EBP1 underlies ALS pathology associated to P56S mutant VAPB.
Helen Cristina Miranda.
#ASHG20 HCM Amyotrophic lateral sclerosis (ALS). Most common type of adult-onset motor neuron disease. About 50% survive past 3rd year diagnosis. 10% familial. 90% sporadic.
#ASHG20 HCM Involves both upper and lower motor neurons. Many genes associated with ALS. >25 genes associated with familial, sporadic, or both versions.
#ASHG20 VF
Impaired eIF5A function causes a craniofacial-neurodevelopmental syndrome that is partially rescued in model systems by spermidine.
Victor Faundes.
#ASHG20 VF by trio whole exome find de novo heterozygous frameshift in EF15A in a patient with a syndrome similar to Kabuki syndrome.
#ASHG20 VF Used Gene Matcher to find additional patients with similar phenotypic featurs. Find additional EIF5A variants in these patients. Developmental delay. Microcephaly, micrognathia.
#ASHG20 DB
Common genetic variants associated with Mendelian disease severity revealed through cryptic phenotype analysis.
David Blair.
#ASHG20 DB Clinical heterogeneity is common rare Mendelian-like diseases. [ I'd go further and say that variation is rule. Just blanket variability is the rule. ]
#ASHG20 DB Looked at morbidity-dependent model for quantitative traits (MDGM). Cryptic phenotype inference (CPA).